-
Mashup Score: 0Submission - 1 year(s) ago
The study was initiated in Q1 2021 and is ongoing. The ultimate goal is to ensure that evidence for (or against) the surrogacy of biomarkers studied in clinical trials of AL amyloidosis can be evaluated and published by the research community without delay. Such data are necessary for evaluating surrogacy and accelerating development of effective therapies. A scientific abstract reporting…
Source: www.herox.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Submission - 1 year(s) ago
The study was initiated in Q1 2021 and is ongoing. The ultimate goal is to ensure that evidence for (or against) the surrogacy of biomarkers studied in clinical trials of AL amyloidosis can be evaluated and published by the research community without delay. Such data are necessary for evaluating surrogacy and accelerating development of effective therapies. A scientific abstract reporting…
Source: www.herox.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Start Solving as an Innovator with HeroX | Sign Up - 1 year(s) ago
Create your profile, find a challenge, and start solving! Join a team or form your own, or go solo. Always free, always open.
Source: www.herox.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Here's how to VOTE TODAY: 1. Go to https://t.co/Lo0sqpU19q 2. Create a free HeroX account 3. Click the "Vote for this submission" button on the HeroX website 4. Click "Yes" 5. Enter your phone number (HeroX's verification system to make sure only one vote per person is cast)
-
-
Mashup Score: 6Start Solving as an Innovator with HeroX | Sign Up - 1 year(s) ago
Create your profile, find a challenge, and start solving! Join a team or form your own, or go solo. Always free, always open.
Source: www.herox.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Submission - 1 year(s) ago
The study was initiated in Q1 2021 and is ongoing. The ultimate goal is to ensure that evidence for (or against) the surrogacy of biomarkers studied in clinical trials of AL amyloidosis can be evaluated and published by the research community without delay. Such data are necessary for evaluating surrogacy and accelerating development of effective therapies. A scientific abstract reporting…
Source: www.herox.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Forum | DataWorks! Challenge | HeroX - 2 year(s) ago
Share your story of how you reused or shared data to further your biological and/or biomedical research effort and get recognized!
Source: www.herox.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 12DataWorks! Challenge | HeroX - 2 year(s) ago
Share your story of how you reused or shared data to further your biological and/or biomedical research effort and get recognized!
Source: www.herox.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @atulbutte: Big $500k @NIH prize highlighted at #nihacd, for winning data sharing and data reuse! Learn more at https://t.co/XEvffeXcOs…
-
-
Mashup Score: 0NASA's Lunar Loo Challenge | HeroX - 4 year(s) ago
Help astronauts go back to the Moon in 2024! NASA seeks new designs for a toilet that will work both in microgravity and lunar gravity.
Source: www.herox.comCategories: Healthcare Professionals, Latest HeadlinesTweet
Today is the last day for voting! The #Amyloidosis Forum (an ARC partnership) has made it through to the final round of the HeroX DataWorks! Challenge! Finalists are eligible for $500,000 prize purse across 12 awards. Help us win and vote here: https://t.co/4EAtEC6qLn